Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotherapy with grouped doses].

S Echechipía1, B E García, M T Aldunate

  • 1Sección de Alergología, Hospital Virgen del Camino, Pamplona.

Anales Del Sistema Sanitario De Navarra
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: Electrolyte Imbalance in Young Infants With Febrile UTI: Is It a Marker of Severity?

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Urinary tract infection screening and referral service from community pharmacy.

Farmaceuticos comunitarios·2026
Same author

Electrolyte Imbalance in Infants Younger Than 90 Days of Age With Febrile Urinary Tract Infection.

Acta paediatrica (Oslo, Norway : 1992)·2025
Same author

Trends in Seafood-Induced Anaphylaxis: Data From the European Anaphylaxis Registry.

The journal of allergy and clinical immunology. In practice·2025
Same author

Safety and Efficacy of the First Venom Immunotherapy for Allergy to Vespa velutina nigrithorax: Interim Analysis of the W-STING Study.

Journal of investigational allergology & clinical immunology·2025
Same author

Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature.

Expert review of hematology·2024
Same journal

[Subacute meningoencephalitis following intravesical BCG instillation immunotherapy].

Anales del sistema sanitario de Navarra·2026
Same journal

[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation].

Anales del sistema sanitario de Navarra·2026
Same journal

[Efficiency after integrating a hospital with a 'new management model'].

Anales del sistema sanitario de Navarra·2026
Same journal

[Anales del Sistema Sanitario de Navarra in 2025: Progress continues].

Anales del sistema sanitario de Navarra·2026
Same journal

Qualitative evaluation of a community intervention in educational centres: Opinion of the professionals involved.

Anales del sistema sanitario de Navarra·2026
Same journal

[Unequal impact of COVID-19 on mortality in long-term care homes across health areas of Castilla-La Mancha (Spain)].

Anales del sistema sanitario de Navarra·2026
See all related articles

Grouped allergen extract immunotherapy offers a faster route to clinical efficacy compared to conventional methods. This optimized dosing strategy reduces treatment time and discomfort while maintaining a similar safety profile.

Area of Science:

  • Allergy and Immunology
  • Pharmacology
  • Clinical Medicine

Background:

  • Subcutaneous immunotherapy (SCIT) with allergen extracts is established but requires optimization.
  • The dose escalation phase of conventional SCIT is lengthy.
  • Alternative dosing strategies are needed to improve efficiency and patient adherence.

Purpose of the Study:

  • To review challenges in designing optimized grouped allergen immunotherapy doses.
  • To present findings from a comparative study of conventional versus grouped SCIT dosing.
  • To evaluate the efficacy and safety of a novel grouped dosing regimen.

Main Methods:

  • Review of existing literature on SCIT dosing strategies.
  • Comparative study employing a double-blind design.

Related Experiment Videos

  • Assessment of clinical efficacy, cutaneous sensitivity, and immunological parameters.

    • Main Results:

    • Grouped dosing significantly shortens the time to achieve clinical efficacy.
    • Reduced time for decreased cutaneous sensitivity to allergens observed.
    • Immunological parameters modified more rapidly with grouped dosing.
    • Adverse reaction frequency was comparable to conventional SCIT.

    Conclusions:

    • Grouped allergen immunotherapy dosing is a viable alternative to conventional SCIT.
    • This approach offers faster efficacy, reduced treatment burden, and comparable safety.
    • Optimized dosing can improve patient adherence and treatment outcomes.